NURS FPX 6021 Assessment 3 Quality Improvement Presentation Poster
Student Name
Capella University
NURS-FPX 6021 Biopsychosocial Concepts for Advanced Nursing Practice 1
Prof. Name
Date
Quality Improvement Methods (DMAIC)
Define Phase
What problem is being addressed? The Define phase identifies the multifactorial contributors to secondary infections in diabetic populations. These include biomedical variables (glycemic instability, peripheral vascular disease), psychosocial factors (health literacy, adherence patterns), demographic variables, and healthcare accessibility constraints. The scope of the initiative is clearly delineated, stakeholders are identified, and specific improvement goals are established.
Measure Phase
How will baseline performance be determined? Quantitative metrics are established to assess infection prevalence, such as infection incidence per 100 diabetic patients within a defined time interval. Additional indicators may include hospital readmission rates, wound healing time, antibiotic utilization, and patient education referral rates. Data integrity and reliability are prioritized to ensure accurate benchmarking.
Analyze Phase
What are the underlying causes of secondary infections? Root Cause Analysis (RCA) techniques—such as fishbone diagrams and failure mode and effects analysis (FMEA)—are used to uncover systemic and behavioral contributors. Identified factors frequently include inadequate patient education, inconsistent hygiene practices, delayed preventive screening, suboptimal glycemic control, and fragmented care coordination.
Improve Phase
What interventions are implemented to address identified gaps? Evidence-based corrective strategies are introduced, including enhanced diabetes self-management education (DSME), standardized hygiene and wound-care protocols, proactive screening initiatives, and structured interdisciplinary communication pathways. Preventive strategies such as foot care reinforcement and appropriate antimicrobial stewardship are integrated to reduce infection susceptibility (Kollipara et al., 2021).
Control Phase
How are improvements sustained over time? Continuous monitoring mechanisms are implemented through dashboards, periodic audits, and feedback loops. Key performance indicators (KPIs) are tracked to prevent regression. Leadership oversight, staff accountability structures, and ongoing education reinforce long-term sustainability (Shi et al., 2022).
Evidence Supporting the Use of DMAIC
What empirical evidence supports DMAIC in healthcare improvement? Research demonstrates that DMAIC enhances process standardization, reduces clinical variation, and improves measurable outcomes. For example, structured patient education initiatives significantly reduce preventable complications in diabetes management (Burks et al., 2020). Similarly, standardized preventive screening protocols implemented through DMAIC frameworks have improved compliance and clinical outcomes (Kollipara et al., 2021).
Table 1 summarizes key evidence supporting the selected improvement methodology.
| Study | Focus Area | Key Findings | Relevance to Project |
|---|---|---|---|
| Burks et al. (2020) | Diabetes education referrals | Lean Six Sigma increased referral rates and engagement | Supports structured education improvements |
| Kollipara et al. (2021) | Diabetic retinopathy screening | DMAIC improved screening adherence | Demonstrates effectiveness of structured QI |
| Shi et al. (2022) | Surgical site infection control | Sustained infection reduction via DMAIC | Validates long-term control strategies |
| Akash et al. (2020) | Diabetes-related infections | Highlighted prevention and antimicrobial strategies | Supports preventive interventions |
| Wicaksana et al. (2020) | Diabetes care management | Emphasized coordinated care during health crises | Reinforces need for interdisciplinary collaboration |
Change Strategy Foundation
Why is DMAIC an appropriate change framework? DMAIC provides a structured, measurable, and replicable process for healthcare quality enhancement. It integrates goal definition, performance measurement, data analysis, and iterative refinement.
Implementation strategies include:
- Establishing SMART (Specific, Measurable, Achievable, Relevant, Time-bound) objectives
- Monitoring clinical and operational metrics
- Implementing preventive policies (e.g., hygiene compliance, antibiotic stewardship)
- Strengthening patient education and follow-up systems (Akash et al., 2020; Wicaksana et al., 2020)
This structured approach minimizes variability while promoting evidence-based decision-making.
Interprofessional Team Benefits
How does interprofessional collaboration enhance outcomes? The initiative incorporates physicians, nurses, pharmacists, infection prevention specialists, and environmental services personnel. This integrated model promotes comprehensive assessment, early intervention, and shared accountability.
Benefits include:
- Improved care continuity
- Enhanced communication across disciplines
- Faster identification of clinical deterioration
- Reduced duplication of services
- Improved patient safety outcomes
Research supports that coordinated interprofessional diabetes management improves both clinical and patient-reported outcomes (Lee et al., 2021).
Limitations of the DMAIC Model
What limitations must be considered?
| Limitation | Description | Mitigation Strategy |
|---|---|---|
| Resistance to Change | Staff reluctance toward workflow modifications | Stakeholder engagement, training programs |
| Data Fragmentation | Lack of integrated electronic health records | Investment in standardized data systems |
| Sustainability Challenges | Resource and leadership dependency | Continuous monitoring and executive support |
Long-term success requires consistent institutional commitment (Shi et al., 2022).
Knowledge Gaps and Areas for Further Study
What areas require additional investigation? Current literature provides limited guidance on integrating psychosocial and behavioral health metrics into DMAIC models. Further research is needed to evaluate:
- Long-term sustainability of infection reduction
- Impact on patient-centered outcomes (satisfaction, quality of life)
- Cost-effectiveness of multidisciplinary interventions
- Integration of social determinants of health into infection risk modeling
Addressing these gaps may strengthen future iterations of quality improvement frameworks.
Potential Challenges and Mitigation Strategies
How can anticipated barriers be addressed?
| Challenge | Impact | Proposed Solution |
|---|---|---|
| Staff Resistance | Delays implementation | Transparent communication and leadership modeling |
| Inconsistent Documentation | Skewed metrics | Standardized documentation training |
| Resource Constraints | Reduced program continuity | Strategic budgeting and administrative advocacy |
Proactive risk mitigation planning enhances implementation fidelity.
Overall Project Benefits
What measurable and systemic benefits are expected?
- Reduced incidence of secondary infections in diabetic patients
- Lower hospitalization and mortality rates
- Improved glycemic control and wound healing outcomes
- Enhanced patient satisfaction and quality of life
- Streamlined care processes with reduced inefficiencies
- Strengthened interprofessional collaboration and accountability
Collectively, these improvements contribute to higher-value healthcare delivery and improved population health outcomes.
References
Akash, M. S. H., Rehman, K., & Fiayyaz, F. (2020). Diabetes-associated infections and treatment strategies.
Burks, J., et al. (2020). Using Lean Six Sigma to improve diabetes education referrals.
Kollipara, U., et al. (2021). Improving diabetic retinopathy screening using DMAIC.
Lee, J. K., et al. (2021). Interprofessional collaboration in diabetes care.
Shi, Z.-Y., et al. (2022). Sustaining improvements in surgical site infections via DMAIC.
Wicaksana, A. L., et al. (2020). Diabetes care considerations during COVID-19.
NURS FPX 6021 Assessment 3 Quality Improvement Presentation Poster.
Shi, Z.-Y., et al. (2022). Sustaining improvements in surgical site infections via DMAIC.
Wicaksana, A. L., et al. (2020). Diabetes care considerations during COVID-19.